Evidence map›Paper›PMID 37199632›Full record

ArticleMicrobiology spectrum2023

SUMO Modification of Hepatitis B Virus Core Mediates Nuclear Entry, Promyelocytic Leukemia Nuclear Body Association, and Efficient Formation of Covalently Closed Circular DNA.

Samuel Hofmann, Verena Plank, Peter Groitl, Nathalie Skvorc, Katharina Hofmann, Julius Luther, Chunkyu Ko, Peter Zimmerman, Volker Bruss, Daniela Stadler and 5 more

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Abnormal protein SUMOylation in liver disease: novel target for therapy.Journal of molecular medicine (Berlin, Germany) · 2024
    Review
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Samuel HofmannInstitute of Virology, School of Medicine, Technical University of Munich, Germany.
Verena PlankInstitute of Virology, School of Medicine, Technical University of Munich, Germany.
Peter GroitlInstitute of Virology, School of Medicine, Technical University of Munich, Germany.
Nathalie SkvorcInstitute of Virology, School of Medicine, Technical University of Munich, Germany.
Katharina HofmannInstitute of Virology, School of Medicine, Technical University of Munich, Germany.
Julius LutherInstitute of Virology, Hannover Medical School, Hannover, Germany.
Chunkyu KoInstitute of Virology, School of Medicine, Technical University of Munich, Germany.
Peter ZimmermanDepartment of Internal Medicine II/Molecular Biology, University Hospital Freiburg, Freiburg, Germany.
Volker BrussInstitute of Virology, Helmholtz Zentrum München, Munich, Germany.
Daniela StadlerInstitute of Virology, School of Medicine, Technical University of Munich, Germany.
Arnaud CarpentierInstitute of Experimental Virology, Twincore, Hannover, Germany.
Shahinda RezkInstitute of Virology, School of Medicine, Technical University of Munich, Germany.
Michael NassalDepartment of Internal Medicine II/Molecular Biology, University Hospital Freiburg, Freiburg, Germany.ORCID 0000-0003-2204-9158
Ulrike ProtzerInstitute of Virology, School of Medicine, Technical University of Munich, Germany.ORCID 0000-0002-9421-1911
Sabrina SchreinerInstitute of Virology, School of Medicine, Technical University of Munich, Germany.ORCID 0000-0002-5744-7159
Helmholtz Zentrum München · DETechnical University of Munich · DEMedizinische Hochschule Hannover · DEUniversity Medical Center Freiburg · DECenter for Experimental and Clinical Infection Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Persistence of hepatitis B virus (HBV) infection is due to a nuclear covalently closed circular DNA (cccDNA), generated from the virion-borne relaxed circular DNA (rcDNA) genome in a process likely involving numerous cell factors from the host DNA damage response (DDR). The HBV core protein mediates rcDNA transport to the nucleus and likely affects stability and transcriptional activity of cccDNA. Our study aimed at investigating the role of HBV core protein and its posttranslational modification (PTM) with SUMO (small ubiquitin-like modifiers) during the establishment of cccDNA. HBV core protein SUMO PTM was analyzed in His-SUMO-overexpressing cell lines. The impact of HBV core SUMOylation on association with cellular interaction partners and on the HBV life cycle was determined using SUMOylation-deficient mutants of the HBV core protein. Here, we show that the HBV core protein is posttranslationally modified by the addition of SUMO and that this modification impacts nuclear import of rcDNA. By using SUMOylation-deficient HBV core mutants, we show that SUMO modification is a prerequisite for the association with specific promyelocytic leukemia nuclear bodies (PML-NBs) and regulates the conversion of rcDNA to cccDNA. By

Indexed as

Hepatitis BHepatitis B virusDNA, CircularDNA, ViralHumansPromyelocytic Leukemia Nuclear BodiesVirus ReplicationDNA, CircularDNA, Viralchronic infectionHBVHBV core proteinPML-NBsSUMO

Identifiers

PMID37199632
PMCPMC10269885
OpenAlexW4377011586

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.